CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Press Release: Ampersand Health x Simplyhealth
25 May 2022
The UK’s leading health and dental plan provider Simplyhealth, has announced it has invested in Ampersand, provider of digital therapies for inflammatory...
HSJ Partnership Awards Win for the Category of “Patient Digital Participation”
22 Mar 2019
Researchers from Mount Sinai Conduct Study Including My IBD Care
20 Sep 2023
Researchers from Mount Sinai, one of the largest teaching hospitals in the US, conducted a study on digital support tools for people with IBD, including My IBD...
Ampersand Health Included in the NHS Elective Recovery Directory
01 Feb 2022
We are pleased to share that we have been included in the NHS elective recovery directory, a resource that highlights the tools available to "streamline...
Ampersand Health Featured in BMJ
22 Jun 2023
Our work on patient initiated follow-up using our My IBD Care app, along with self-monitoring of calprotectin through our CalproSmart™ ™ integration,...